Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators

Lund, Sweden, April 30, 2024 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today congratulates its partner ClearPoint Neuro on receiving 510(k) clearance for its Prism Bone Anchor Accessory, expanding the use of ClearPoint Prism Neuro Laser Therapy System beyond the MRI into the operating room.The introduction of the Prism Bone Anchor Accessory for use with the ClearPoint Prism Neuro Laser Therapy System and commercially available stereotactic systems allows for placement of laser applicators also in the operating room.   “The 510(k) clearance of the Prism Bone

Archer Limited: Archer secures a 2-year contract extension worth USD 40 million

Hamilton Bermuda, (April 30, 2024) Archer has been awarded a two-year contract extension for platform drilling services in the UK with an estimated contract value of USD 40 million. The extension will commence 1[st] May 2024 in direct continuation of the current contract. Over the next two years Archer will continue to deliver drilling operations, maintenance and rig reactivation services for the customer. Alexander Olsson, EVP Platform Operations in Archer comments: ‘’We are delighted that Archer was elected to continue the work for our client. This contract extension reflects our

MEDIVIR AB – INTERIM REPORT JANUARY – MARCH 2024

”Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months”   January – MarchFinancial summary for the quarter · Net turnover amounted to SEK 0.5 (0.4) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -26.7 (-18.9) million. Basic and diluted earnings per share amounted to SEK -0.23 (-0.34) and SEK -0.23 (-0.34) respectively. · Cash flow from operating

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q1 2024

For the second year in a row, we show a positive operating profit for the first quarter. This despite weak construction and consumer markets that resulted in a negative sales development of -12% to MSEK 38.2 (43.5). Thanks to a positive change in product mix and good sales of our own consumer brands, the Group’s gross margin strengthened to 29 (26) %. This, in combination with sound cost control, resulted in a slightly improved operating profit of MSEK 0.2 (0.1).Translation from CEO Mårten Hellbergs comments to the Interim Report. Q1, 1 January - 31 March 2024 The Group compared with

Safello enters into framework agreement with the Swedish Economic Crime Authority

Stockholm, April 30, 2024 | Safello, the leading cryptocurrency exchange in the Nordics, has entered into a framework agreement with the Swedish Economic Crime Authority. The framework agreement between the parties was concluded following a public procurement process conducted by the Swedish Police Authority to meet the needs of the Police Authority, the Swedish Customs Service, and the Economic Crime Authority for cryptocurrency services, which Safello won in August 2023. The procurement was carried out in accordance with the Swedish Public Procurement Act (Lagen om offentlig upphandling, “

Sigrid Therapeutics Surpasses the 50% Enrollment Milestone in its Clinical Trial, SHINE, to Evaluate the SiPore21® Gel for Sustained Diabetes and Obesity Control

· SHINE is the largest ongoing clinical study of its kind, marking a milestone in research on prediabetes and weight control. It involves individuals who are living with excess weight or obesity and have prediabetes or type 2 diabetes. · SiPore21® Silica "Molecular Sieves" is a promising, non-pharmaceutical oral alternative to injectable drugs for sustainable weight control.Stockholm, April 30th, 2024: Sigrid Therapeutics announced today that it has enrolled more than half of the necessary participants for its clinical trial SHINE of SiPore21®. SHINE is a randomized, double-blind,

Resand's solution helps Valmet's foundry industry to increase sand recycling rate

Resand Ltd, press release 30 April 2024 at 9.30 a.m. EESTThe cooperation between Resand Oy, which specializes in foundry sand regeneration and recycling, and Valmet Corporation will expand with the Sand As A Service agreement signed in December 2023. The new agreement includes an environmentally friendly sand recovery and recycling service. The service will significantly increase the recycling rate of the sand used by Valmet's Jyväskylä foundry, while at the same time reducing transport and emissions. The Resand[® ](SAAS) solution offers foundries sustainable savings compared to current

Receives new patent in China

VibroSense Dynamics AB (VibroSense) has got a patent approval in China. The patent describes a principle for measuring skin temperature wirelessly before and during an examination, which ensures measurement quality.Obtaining the patent in China is part of a long-term strategy to protect VibroSense intellectual property rights. The patent protection will be further strengthened by several patent applications currently pending in various countries around the world. The current patent for wireless measurement of skin temperature was approved in Sweden in 2019.VibroSense strategy to protect

The shares in DNB Bank ASA will be quoted ex-dividend today

The shares in DNB Bank ASA will be quoted ex-dividend today (30 April 2024). A dividend of NOK 16 per share will be distributed from 8 May 2024 to shareholders as at 29 April 2024.  For further information, please contact:  Rune Helland, Head of Investor Relations, tel. (+47) 232 68 400 / (+47) 977 13 250 This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act.

Dolphin Drilling AS - 2023 Annual Report and ESG report

(Oslo, 30 April 2024) Dolphin Drilling AS (Dolphin Drilling, OSE: DDRIL), has today published the company's Annual Report and ESG report for 2023. The report is attached to this press release and available on www.dolphindrilling.com/Investor Relations. For further information, please contact: Ingolf Gillesdal, Corporate Finance and Investor Relations, tel: +47 920 45 320 Dolphin Drilling | www.dolphindrilling.com

The Swedish Competition Authority prohibits Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB

Oriola Corporation  Stock Exchange Release  30 April 2024 at 9:15 a.m. EEST The Swedish Competition Authority prohibits Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB The Swedish Competition Authority (Konkurrensverket) has announced its decision on prohibiting Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB due to negative effects on the competition in the market. Oriola announced on 13 October 2023 the sale of all shares in Svensk dos AB to Apotekstjänst Sverige AB. Oriola has starting from that announcement communicated that it has not identified a

Pasi Päivärinta appointed as interim CFO of Caverion

Caverion Corporation Stock exchange release 30 April 2024 at 9:00 EETPasi Päivärinta appointed as interim CFO of Caverion Pasi Päivärinta, Head of Group Business Control, has been appointed as interim CFO of Caverion Corporation as of 1 May 2024. He reports to President and CEO of Caverion Corporation Jacob Götzsche and Philip Carlsson, CFO of Assemblin Caverion Group. Päivärinta has worked in the company since 2018. As announced earlier, Caverion Corporation and Assemblin Group AB combined on 1 April 2024 to create a leading northern European technical service and installation

The DOF group awarded multiple contracts with Petrobras

DOF is pleased to announce that Petrobras has awarded new long-term charter and service contracts to Norskan Offshore Ltda. and DOF Subsea Servicos Brasil Ltda, after a competitive tender process.  The vessel Skandi Amazonas (324 t BP) that was on the spot market is chartered for 3 years firm with 2 years mutually agreed option via Petrobras tender issued late in 2023, to operate as a AHTS 270t BP. Vessel is now in process to be adapted to Petrobras contract with expectations to be delivered by mid-May / mid-June 2024. Skandi Rio (206 t BP), currently operating for Petrobras and

Angler Gaming PLC publishes Annual and Sustainability Report for 2023

2023: the return to strong growth, profit and innovationThomas Kalita, CEO, comments: “The results of 2023 reveal good momentum within the Group. Revenues increased 23.7% and Net Profit increased 164.7%. During the year the Group continued to add innovative functions into its competitive proprietary i-Gaming platform. In addition, the increased B2B activities, investment in people, tightened cost control and embracing new business verticals all contributed to a successful 2023 and an optimistic outlook for 2024."

Change in the number of shares and votes in Alligo AB (publ)

According to Alligo’s articles of association, owners of Series A shares are entitled to request that such shares be converted to Series B shares. Conversion reduces the total number of voting rights in the company.During April 2024, 1,780 Series A shares were converted to Series B shares at the request of shareholders. On 30 April 2024, the last trading day of the month, the total number of votes in the company was 55,966,826. The total number of registered shares in the company amount to 50,906,189 of which 562,293 are Series A and 50,343,896 are Series B. Alligo holds 855,300 Series B

Conversion of shares

According to SCA’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.In April, at the request of shareholders 57 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,282,258,317.The total number of registered shares in the company amounts to 702,342,489 of which 64,435,092 are Class A shares and

Conversion of shares

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.In April, at the request of shareholders, 57 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,251,072,363. The total number of registered shares in the company amounts to 702,342,489 of which 60,969,986 are Class A

Impala Bondco plc - Delayed publication of the 2023 Audited Financial Report

30 April 2024 - REGULATORY Impala Bondco plc, trading as Impero, will delay the publication of the Audited Financial Report for the Fiscal Year that ended on 31st December, 2023.  The Company expects to publish the Audited Financial Report by no later than Monday, May 27[th], 2024. Given the recent appointment of a new Senior Management Team, additional time is required for review and approval of the report. For further information please contact Adrian Muniz, CFO This information is information that Impala Bondco plc is obliged to make public pursuant to the EU Market Abuse

Wetteri's annual report 2023 and corporate governance statement for 2023 have been published

Wetteri Plc Stock exchange release 30 April 2024 at 9:00 EETWetteri  Plc has today published its annual report for 2023. The annual report includes the Board of Director’s report, the consolidated financial statements, the parent company's financial statements, the auditor's report, the corporate governance statement and the remuneration report for the year 2023. Wetteri Plc has also published its financial statements in accordance with the European Single Electronic Format (ESEF) reporting requirements in XHTML format marked with XBRL tags and it is available as a zip file attached to this

Stora Enso: Managers’ transactions – Helena Hedblom

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 30 April 2024 at 9:00 EESTStora Enso’s Annual General Meeting on 20 March 2024 resolved that the annual remuneration for the members of the Board of Directors be paid in Company shares and cash, so that 40% will be paid in Stora Enso R shares to be purchased on the Board members’ behalf, and the rest in cash. In accordance with this resolution, Helena Hedblom has received shares as follows: Stora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Helena Hedblom

Stora Enso: Managers’ transactions – Elisabeth Fleuriot

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 30 April 2024 at 9:00 EESTStora Enso’s Annual General Meeting on 20 March 2024 resolved that the annual remuneration for the members of the Board of Directors be paid in Company shares and cash, so that 40% will be paid in Stora Enso R shares to be purchased on the Board members’ behalf, and the rest in cash. In accordance with this resolution, Elisabeth Fleuriot has received shares as follows: Stora Enso OYJ - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Elisabeth

Stora Enso: Managers’ transactions – Richard Nilsson

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 30 April 2024 at 9:00 EESTStora Enso’s Annual General Meeting on 20 March 2024 resolved that the annual remuneration for the members of the Board of Directors be paid in Company shares and cash, so that 40% will be paid in Stora Enso R shares to be purchased on the Board members’ behalf, and the rest in cash. In accordance with this resolution, Richard Nilsson has received shares as follows: Stora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Richard

Stora Enso: Managers’ transactions – Reima Rytsölä

STORA ENSO OYJ MANAGERS’ TRANSACTIONS 30 April 2024 at 9:00 EESTStora Enso’s Annual General Meeting on 20 March 2024 resolved that the annual remuneration for the members of the Board of Directors be paid in Company shares and cash, so that 40% will be paid in Stora Enso R shares to be purchased on the Board members’ behalf, and the rest in cash. In accordance with this resolution, Reima Rytsölä has received shares as follows: Stora Enso Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Reima Rytsölä

There are no items matching the current filter
There are no more items matching the current filter
Back to top